Results 31 to 40 of about 86,774 (206)

Oral administration of Clostridium butyricum rescues streptomycin-exacerbated respiratory syncytial virus-induced lung inflammation in mice

Virulence, 2021
Changes in the intestinal microbiota indirectly impact the health of mucosa distal to the intestine, particularly the respiratory tract. However, the effects of intestinal microbiota dysbiosis on the regulation of respiratory syncytial virus (RSV ...
Wenwen Zhu, Jia Wang, Na Zhao, Rui Zheng, Dalu Wang, Weiwei Liu, Beixing Liu   +6 more
doaj   +1 more source

Serum RSV- and HPIV3-neutralizing antibody responses in hamsters following intranasal inoculation with rHPIV3-RSV-F vectors and wt RSV.

, 2020
Additional hamsters in groups of 6 were inoculated as described in the legend to Fig 5 with the indicated HPIV3-RSV-F vectors, or the B/HPIV3 vector GS/DS-Cav1/B3TMCT, or wt RSV. (A, B) Serum RSV-neutralizing antibody titers.
Sonja Surman (185609), Barney S. Graham (7400855), Xiang Liu (119470), Emerito Amaro-Carambot (185611), Xueqiao Liu (765408), Peter L. Collins (7252565), Peter D. Kwong (161423), Shirin Munir (223824), Bo Liang (450389)   +8 more
core   +1 more source

The incidence and clinical burden of respiratory syncytial virus disease identified through hospital outpatient presentations in Kenyan children [PDF]

, 2012
There is little information that describe the burden of respiratory syncytial virus (RSV) associated disease in the tropical African outpatient setting. Methods We studied a systematic sample of children aged
Bett, Ann, Okiro Emelda A., D James Nokes, Ann Bett, Bett Ann, Emelda A Okiro, Ngama Mwanajuma, Nokes D. James, Nokes, D. James, Mwanajuma Ngama, Ngama, Mwanajuma, Okiro, Emelda A.   +11 more
core   +1 more source

Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease

Drug, Healthcare and Patient Safety, 2023
Shaun O’Hagan,1,2 Niamh Galway,3 Michael D Shields,3,4 Peter Mallett,1,4 Helen E Groves1,2 1Paediatric Infectious Diseases, Royal Belfast Hospital for Sick Children, Belfast, Northern Ireland; 2Wellcome-Wolfson Institute for Experimental Medicine, Queen ...
O'Hagan S, Galway N, Shields MD, Mallett P, Groves HE   +4 more
doaj  

A multifaceted approach to RSV vaccination

Human Vaccines & Immunotherapeutics, 2018
Respiratory Syncytial Virus (RSV) is the leading cause of pneumonia and bronchiolitis in infants, resulting in significant morbidity and mortality worldwide.
Jorge C. G. Blanco, Marina S. Boukhvalova, Trudy G. Morrison, Stefanie N. Vogel   +3 more
doaj   +1 more source

The ABCs of RSV

The Nurse Practitioner, 2018
Abstract: Respiratory syncytial virus (RSV) is a common viral infection affecting many children in the United States. This seasonal virus is the leading cause of hospitalization of infants and neonates. This article reviews the current recommendations for diagnostic testing, treatment options, and prevention of RSV.
openaire   +3 more sources

Non-Coding RNAs and Their Role in Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Infections

Viruses, 2020
Recent high-throughput sequencing revealed that only 2% of the transcribed human genome codes for proteins, while the majority of transcriptional products are non-coding RNAs (ncRNAs).
Wenzhe Wu, Eun-Jin Choi, Inhan Lee, Yong Sun Lee, Xiaoyong Bao   +4 more
doaj   +1 more source

RSV-specific IgG titer and RSV-IgG avidity do not correlate with disease severity.

, 2017
RSV-specific IgG levels in plasma of infants was determined by ELISA using virus particles. RSV-IgG avidity was assessed by supplementing NaSCN during ELISA. (A) RSV-specific IgG levels were displayed versus age.
Ivy Widjaja (128545), Ronald de Groot (54924), Oliver Wicht (440906), Willem Luytjes (349214), Teun Guichelaar (3704830), Jop Jans (3704833), Gerben Ferwerda (60600), Marien I. de Jonge (527369), Inge M. L. Ahout (3704827), Cornelis A. M. de Haan (90844)   +9 more
core   +1 more source

Effectiveness of long-acting monoclonal antibodies against laboratory-confirmed RSV in children aged < 24 months and hospitalised for severe acute respiratory infection, European pilot study, 2024 to 2025

Eurosurveillance
We measured effectiveness of nirsevimab against laboratory-confirmed respiratory syncytial virus (RSV) infection in a test-negative case-control study among children aged 
VEBIS hospital network RSV IE group
doaj   +1 more source

microRNAs in viral acute respiratory infections: immune regulation, biomarkers, therapy, and vaccines [PDF]

ExRNA, 2019
MicroRNAs (miRNAs) are single-stranded RNAs of 17–24 nt. These molecules regulate gene expression at the post-transcriptional level and are differentially expressed in viral acute respiratory infections (ARIs), which are responsible for high morbidity ...
Stephen A. Leon-Icaza, Mingtao Zeng, Adrian G. Rosas-Taraco   +2 more
doaj   +1 more source